Who is sponsoring NCT05526508?

NCT05526508 is sponsored by Buckinghamshire New University.

What drugs are being tested in NCT05526508?

Interventions in NCT05526508: Rebound exercise.

What condition does NCT05526508 study?

NCT05526508 studies Neurological Diseases or Conditions.

Is NCT05526508 still recruiting?

NCT05526508 is currently status unknown. Last updated 15 February 2023.

Last reviewed 2023-02-15 · How we verify

NCT05526508

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rebound Exercise in Neurological Disorders

Status unknown NA Last updated 15 February 2023

What this trial tests

NA trial testing Rebound exercise in Neurological Diseases or Conditions in 52 participants. Status unknown.

Timeline

12 December 2022

Primary endpoint
30 June 2023

31 July 2023

Quick facts

Lead sponsor	Buckinghamshire New University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	52
Start date	12 December 2022
Primary completion	30 June 2023
Estimated completion	31 July 2023
Sites	2 locations across United Kingdom

Drugs / interventions tested

Rebound exercise

Conditions studied

Neurological Diseases or Conditions — all drugs for Neurological Diseases or Conditions →

Sponsor

Buckinghamshire New University

Who can join

Adults 18 to 80, any sex, with Neurological Diseases or Conditions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be a pretest-posttest interventional trial investigating the use of rebound exercise in community-dwelling individuals with neurological disorders.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Rebound exercise

Trials testing the same drug.

NCT03200795 — Effect of Different Exercises on Musculoskeletal Pain,Glucose Level and Quality of Life Among Patients With Diabetes · NA · unknown

Other recruiting trials for Neurological Diseases or Conditions

Currently open trials in the same condition.

NCT07254663 — GEL & MEDication Dysphagia · recruiting
NCT06504433 — The Natural History of Mitochondrial Diseases · recruiting
NCT04806620 — Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research · recruiting
NCT05645003 — Transcranial Magnetic Stimulation Therapy in Neuropathic Painful Spinal Cord Injury Patients · NA · recruiting
NCT04706481 — Archival of Human Biological Samples in CU-Med Biobank · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05526508 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Buckinghamshire New University
Last refreshed: 15 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05526508.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing